I don’t know how to feel about this blog post to be quite honest. I know that the allocation & final rules vary organ to organ, so I can only speak to lungs, not liver. I wish though, that the Health Affairs Blog would have made that distinction in the title of this post because this clearly only addresses livers. Not other organs in contrast or comparison, so it’s not a wholly balanced discussion.
This HealthDay article really struck a cord when I read it. It’s not only the kidney population that sometimes has issues with the process of when to refer or list, it’s other organs too. But it’s compelling food for thought for patients and professionals, as transplantation is a treatment, but not a cure. They are also costly, but overall may be less costly than other long-term interventions that don’t offer many of the benefits & the possible quality of life improvements that transplants do. As I was reading that article, certain paragraphs resonated with me, but as much as we try and contribute this to a professional issue of late referrals, I personally believe there’s more to it.